Institution
Roussel Uclaf
About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid
Papers published on a yearly basis
Papers
More filters
•
20 Sep 1982TL;DR: In this article, the triazoloquinazolones were used as ingredients for anti-histamines and bronchospasmolytiques, including anti-malignancy agents.
Abstract: L'invention concerne les triazoloquinazolones The invention relates triazoloquinazolones ou R et R' sont hydrogene, halogene, alcoyle ou alcoxy (1 a 3 carbones) et nitro, Y est alcoyle (1 a 6 carbones), cycloalcoyle (3 a 8 carbones), alcenyle (2 a 4 carbones), aryle ou aralcoyle (6 a 8 carbones), B est wherein R and R 'are hydrogen, halogen, alkyl or alkoxy (1-3 carbons) and nitro, Y is alkyl (1 to 6 carbons), cycloalkyl (3 to 8 carbons), alkenyl (2-4 carbons), aryl or aralkyl (6 to 8 carbons), B is ou alcoylene -(CH 2 )n- ou n est 1, 2 ou 3, alkylene or - (CH 2) n- wherein n is 1, 2 or 3, ou R 1 et R 2 sont hydrogene, alcoyle (1 a 6 carbones), cycloalcoyle (3 a 8 carbones), aryle ou aralcoyle (6 a 8 carbones), aminoalcoyle, monoalcoyle ou dialcoylaminoalcoyle (alcoyles de 2 a 4 carbones, piperidinoalcoyle, morpholinoalcoyle ou piperazinylalcoyle, ou R, et R 2 forment avec l'azote un heteroxycle sature mono ou bicyclique (4 a 8 carbones), pouvant porter 1 ou 2 methyles, ou renfermer un oxygene, un soufre ou un azote qui peut etre substitue par alcoyle (1 a 3 carbones), hydroxyalcoyle (1 a 3 carbones), aryl ou aralcoyle (6 a 8 carbones) ou alcoxycarbonyle (2 a 5 carbones) ou X est wherein R 1 and R 2 are hydrogen, alkyl (1 to 6 carbons), cycloalkyl (3 to 8 carbons), aryl, or aralkyl (6 to 8 carbons), aminoalkyl, monoalkyl or dialkylaminoalkyl (alkyl from 2 to 4 carbons, piperidinoalcoyle, morpholinoalcoyle or piperazinylalcoyle, or R, and R 2 form with the nitrogen a saturated mono or bicyclic heteroxycle (4-8 carbons), which may have 1 or 2 methyl or contain oxygen, sulfur or nitrogen which may be substituted by alkyl (1-3 carbons), hydroxyalkyl (1-3 carbons), aryl or aralkyl group (6-8 carbons) or alkoxycarbonyl (2 to 5 carbons) or X is leurs sels avec les acides, leur preparation, leur application comme medicaments notamment antihistaminiques et bronchospasmolytiques. salts with acids, their preparation, their use as medicaments including antihistamines and bronchospasmolytic. les compositions les renfermant et des intermediaires nouveaux. compositions containing them and novel intermediates.
7 citations
••
TL;DR: This project had a technological aim to qualify the design and the technologies used, and a more scientific one to improve understanding of the phenomena involved in this process.
7 citations
•
12 May 1982TL;DR: In this paper, the syn isomers of optically active isomers and racemates of 7-[2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido]-bicyclooctene-carboxylic acid derivatives of the formula ##STR1## were selected from the group consisting of hydrogen, an alkali metal, --NH 4, alkaline earth metal equivalent, a non-toxic, pharmaceutically acceptable organic amine and an easily cleavable ester group.
Abstract: Novel syn isomers of optically active isomers and racemates of 7-[2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido]-bicyclooctene-carboxylic acid derivatives of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, optionally substituted alkyl of 1 to 6 carbon atoms and optionally substituted alkenyl and alkynyl of 2 to 6 carbon atoms, R 1 is selected from the group consisting of hydrogen, methyl, halomethyl, hydroxymethyl and acyloxymethyl, X is selected from the group consisting of oxygen and optionally oxidized sulfur, A is selected from the group consisting of hydrogen, an alkali metal, --NH 4 , alkaline earth metal equivalent, a non-toxic, pharmaceutically acceptable organic amine and an easily cleavable ester group and their non-toxic, pharmaceutically acceptable acid addition salts having antibiotic activity and their preparation.
7 citations
•
06 Jan 1993TL;DR: A compound selected from the group consisting of a compound of the formula "STR1" wherein R 1 is selected from a group consisting consisting of R 13, R 14 and R 15 are individually selected from each of the groups consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms, n is an integer from 0, 1, 2 or 3; Hal, Hal 1, Hal 2 and Hal 3 are individually halogen; and R 8, R 9, R 10, R 11, R 12, R 13 and R 14 are individually any of the
Abstract: A compound selected from the group consisting of a compound of the formula ##STR1## wherein R 1 is selected from the group consisting of ##STR2## R 13 , R 14 and R 15 are individually selected from the group consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms, n is an integer from 1 to 3, R 2 is hydrogen or alkyl of 1 to 3 carbon atoms, R 3 , R 4 R 5 , R 6 and R 7 are individually selected from the group consisting of hydrogen, halogen, --NO 2 , --CN, alkyl, alkylthio and alkoxy of 1 to 6 carbon atoms, alkylcarbonyl of 2 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, ##STR3## m is 0, 1, 2 or 3, n is 1, 2 or 3; Hal, Hal 1 , Hal 2 and Hal 3 are individually halogen and ##STR4## R 8 , R 9 , R 10 , R 11 and R 12 are individually any of the groups defined above for R 3 , R 4 , R 5 , R 6 and R 7 or R 4 and R 5 together form --O--CH 2 --O-- and their non-toxic, pharmaceutically acceptable base addition salts having anti-inflammatory activity.
7 citations
Authors
Showing all 1888 results
Name | H-index | Papers | Citations |
---|---|---|---|
Fernand Labrie | 110 | 885 | 48308 |
Lionel H. Opie | 84 | 519 | 25964 |
Alain Bélanger | 70 | 244 | 16469 |
Michel J. Tremblay | 53 | 273 | 10485 |
Pierre Monsan | 51 | 216 | 8049 |
Samir Z. Zard | 50 | 575 | 10739 |
Alejandro Aruffo | 47 | 123 | 14084 |
Samuel S.C. Yen | 47 | 96 | 6865 |
Dominique Maraninchi | 47 | 188 | 8108 |
Serge Erlinger | 46 | 152 | 8200 |
Romain Lefebvre | 40 | 221 | 5269 |
William B. Motherwell | 39 | 305 | 6357 |
Jean-Pierre Raynaud | 38 | 104 | 5075 |
André Lemay | 38 | 114 | 4264 |
Patrick J. Creaven | 32 | 102 | 3435 |